MitoPharm Corporation

26 articles about MitoPharm Corporation

• MitoPharm Corporation Begins Production of Its Anti-Aging Products

  10/16/2007

• MitoPharm Corporation Shareholders Conference Call

  10/4/2007

• MitoPharm Corporation Announces Dividend Update

  9/20/2007

• MitoPharm Corporation Schedules Special Shareholder Conference Call to Discuss Successful Business Activities and Upcoming Corporate Initiatives

  9/18/2007

• MitoPharm Corporation Increases and Escalates Shareholder Dividend

  9/4/2007

• MitoPharm Corporation Board Approves a 200% Stock Dividend

  8/27/2007

• MitoPharm Corporation Appears in USA Today

  8/24/2007

• MitoPharm Corporation's Compound, Schisandrin B, Has Been Shown to Protect the Liver Against Chemical Toxin-Induced Damage

  8/23/2007

• MitoPharm Corporation Receives Notice of a U.S. Patent Allowance for Its Newly Discovered Compound

  8/21/2007

• New Study to Highlight MitoPharm Corporation's Schisandrin B Ability to Protect Against Heart Damage

  8/7/2007

• Hong Kong University of Science and Technology to Award Exclusive License to MitoPharm Corporation

  8/7/2007

• Hong Kong University of Science and Technology Awards Exclusive License to MitoPharm Corporation

  8/6/2007

• MitoPharm Corporation Founder Dr. Robert Ko in Collaboration with Dr. Ka-Ming Ng and the Hong Kong University of Science and Technology Develops New Innovation for Extraction Process

  8/1/2007

• MitoPharm Corporation Announces That Patented Use of This Newly Discovered Compound, (-) Schisandrin B, for the Prevention and Treatment of Ischemic Heart Disease Has Been Applied for With the US Patent and Trademark Office

  6/25/2007

• Recent Study Finds MitoPharm Corporation's Schisandrin B Possesses an Optimal Molecule Structure for Conferring Protection Against Heart Damage

  6/18/2007

• MitoPharm Corporation: New Findings Strengthen the Belief That Schisandrin B Can Serve as a Heart Protecting Agent

  6/8/2007

• MitoPharm Corporation: Investigation Findings, Corroborated by Empirical Evidence of the Schisandra Berry as Cardio-Tonic in Traditional Chinese Medicine for Hundreds of Years, Support the Use of Schisandrin B in the Prevention and Treatment of IHD

  5/29/2007

• MitoPharm Corporation's Test Findings Support the Notion That Schisandrin B Serves as an All-Round Protecting Agent Against Free Radical-Induced Cellular Injury

  5/24/2007

• MitoPharm Corporation Targets Baby Boomers, Positions Functional Beverages, Dietary Supplements and Drugs- MitoPharm Corporation's Anti-Aging Products for the Baby Boom Generation

  5/23/2007

• MitoPharm Corporation Test Results Indicate That Schisandrin B Not Only Protects Against Liver Damage Caused by Tacrine, But Also Produces Memory-Enhancing Effect

  5/22/2007